Medicalgorithmics S.A. (WSE:MDG)
33.05
+0.65 (2.01%)
At close: Dec 5, 2025
Medicalgorithmics Revenue
Medicalgorithmics had revenue of 7.19M PLN in the quarter ending September 30, 2025, with 38.03% growth. This brings the company's revenue in the last twelve months to 26.80M, down -12.64% year-over-year. In the year 2024, Medicalgorithmics had annual revenue of 24.00M, down -44.31%.
Revenue (ttm)
26.80M
Revenue Growth
-12.64%
P/S Ratio
12.28
Revenue / Employee
229.03K
Employees
117
Market Cap
328.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 24.00M | -19.10M | -44.31% |
| Dec 31, 2023 | 43.10M | -19.62M | -31.28% |
| Dec 31, 2022 | 62.72M | 14.37M | 29.72% |
| Dec 31, 2021 | 48.35M | -63.39M | -56.73% |
| Dec 31, 2020 | 111.73M | -62.14M | -35.74% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.30B |
| NEUCA | 13.34B |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 568.83M |
| Celon Pharma | 225.60M |
| Selvita | 373.90M |
| Ryvu Therapeutics | 90.41M |
| Centrum Medyczne ENEL-MED | 820.59M |